These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2919745)

  • 1. Cisplatin in isolated limb perfusion.
    Roseman JM
    Am J Surg; 1989 Mar; 157(3):366. PubMed ID: 2919745
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremities.
    Pommier RF; Moseley HS; Cohen J; Huang CS; Townsend R; Fletcher WS
    Am J Surg; 1988 May; 155(5):667-71. PubMed ID: 3369621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
    Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
    Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolated limb hyperthermic perfusion chemotherapy for melanoma of the extremities].
    Li J; Wang P; Zhu XJ; Song JG; Song JM
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):937-9. PubMed ID: 23336382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolated hyperthermic perfusion of the extremities with cytostatic agents. A method of treatment in malignant melanoma and soft tissue sarcoma].
    Kettelhack C; Schlag P
    Dtsch Krankenpflegez; 1989 Sep; 42(9):597-601. PubMed ID: 2518209
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics and results of dose escalation in cis-platin hyperthermic isolation limb perfusion.
    Fletcher WS; Pommier RF; Woltering EA; Mueller CR; Ash KO; Small KA
    Ann Surg Oncol; 1994 May; 1(3):236-43. PubMed ID: 7842294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of regional chemotherapy in the management of extremity soft tissue malignancies.
    Smith HG; Hayes AJ
    Eur J Surg Oncol; 2016 Jan; 42(1):7-17. PubMed ID: 26382102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hyperthermic perfusion in the treatment of tumors of the extremities.
    Di Filippo F; Carlini S; Cavaliere F; Giannarelli D; Cavallero L; Moscarelli F; Aloe L; Cavaliere R
    Adv Exp Med Biol; 1990; 267():223-34. PubMed ID: 2088040
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional perfusion for malignant melanoma and soft tissue sarcoma: a review.
    Muchmore JH; Carter RD; Krementz ET
    Cancer Invest; 1985; 3(2):129-43. PubMed ID: 3888352
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolated limb perfusion with cisplatin and doxorubicin for locally advanced soft tissue sarcoma of an extremity.
    Eroglu A; Kocaoglu H; Demirci S; Akgül H
    Eur J Surg Oncol; 2000 Apr; 26(3):213-21. PubMed ID: 10753532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxics and hyperthermic perfusion: a preliminary study.
    Tonak J; Hermanek P; Banz H; Groitl H
    Cancer Treat Rev; 1979 Jun; 6 Suppl():135-41. PubMed ID: 498167
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas].
    Tonak J; Hohenberger W; Göhl J
    Chirurg; 1984 Aug; 55(8):499-504. PubMed ID: 6488994
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperthermic isolated limb perfusion. The switch from Steinmann pins to Omni-tract assisted isolation.
    Stamatiou D; Ioannou CV; Kontopodis N; Michelakis D; Perisinakis K; Lasithiotakis K; Zoras O
    J Surg Res; 2017 Jun; 213():147-157. PubMed ID: 28601307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer therapy with isolated limb perfusion].
    Spasojevic M; Mariathasan AB; Frich L; Bruland ØS; Larsen SG; Stoldt S
    Tidsskr Nor Laegeforen; 2021 Sep; 141(2021-12):. PubMed ID: 34505491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermic isolated limb perfusion for recurrent melanomas and soft tissue sarcomas: feasibility and reproducibility in a multi-institutional Hellenic collaborative study.
    Lasithiotakis K; Economou G; Gogas H; Ioannou C; Perisynakis K; Filis D; Kastana O; Bafaloukos D; Decatris M; Catodritis N; Frangia K; Papadakis G; Magarakis M; Tsoutsos D; Chrysos E; Chalkiadakis G; Zoras O
    Oncol Rep; 2010 Apr; 23(4):1077-83. PubMed ID: 20204294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of age on outcomes after isolated limb perfusion for advanced extremity malignancies.
    Smith HG; Wilkinson MJ; Smith MJF; Strauss DC; Hayes AJ
    Eur J Cancer; 2018 Sep; 100():46-54. PubMed ID: 29940423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolated hyperthermic extremity perfusion in soft tissue sarcoma].
    Eigler FW; Krause U
    Chirurg; 1997 Jun; 68(6):649. PubMed ID: 9324449
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolated limb perfusion: the European experience.
    Lejeune FJ; Kroon BB; Di Filippo F; Hoekstra HJ; Santinami M; Liénard D; Eggermont AM
    Surg Oncol Clin N Am; 2001 Oct; 10(4):821-32, ix. PubMed ID: 11641093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Soft tissue sarcoma: isolated hyperthermic extremity perfusion. Technique and indications].
    Schlag PM; Kettelhack C
    Chirurg; 1993 Jun; 64(6):455-60. PubMed ID: 8359057
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective management of extremity cancers using cisplatin and etoposide in isolated limb perfusions.
    Roseman JM
    J Surg Oncol; 1987 Jul; 35(3):170-2. PubMed ID: 3599991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.